Pure Biologics

Pure Biologics EBIT per Share

The EBIT per Share of Pure Biologics (PUR.WA) as of Sep 27, 2026 is -1.53 PLN. In the previous year, EBIT per Share was -4.27 PLN — a change of -64.28% (higher).

EBIT per Share

-1.53PLN

YoY

-64.28%

Last updated:

EBIT per Share of Pure Biologics is 2026 -1.53 PLN. EBIT per Share of Pure Biologics was 2025 -4.27 PLN. It decreases by -64.28% higher compared to the previous year.

The Pure Biologics EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2017
-0.38 PLN
Jan 1, 2018
-0.54 PLN
Jan 1, 2019
-2.64 PLN
Jan 1, 2020
-6.99 PLN
Jan 1, 2021
-4.72 PLN
Jan 1, 2022
-4.77 PLN
Jan 1, 2023
-4.27 PLN
Jan 1, 2024
-1.53 PLN
The Pure Biologics EBIT per Share history
YEAREBIT per ShareYoY
-1.53PLN-64.28%
-4.27PLN-10.47%
-4.77PLN+1.05%
-4.72PLN-32.40%
-6.99PLN+164.58%
-2.64PLN+390.56%
-0.54PLN+42.98%
-0.38PLN-19.24%
-0.47PLN—
Access this data via the Eulerpool API
Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

EBIT per Share of Pure Biologics is -1.53 PLN in 2026.

EBIT per Share of Pure Biologics changed from -4.27 PLN to -1.53 PLN, representing a -64.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Pure Biologics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pure Biologics